Elsevier

Neurobiology of Aging

Volume 36, Issue 2, February 2015, Pages 1209-1220
Neurobiology of Aging

Regular article
Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction

https://doi.org/10.1016/j.neurobiolaging.2014.10.037Get rights and content

Abstract

The pathologic hallmark of Parkinson's disease (PD) is the accumulation of alpha-synuclein (αsyn) in susceptible neurons in the form of Lewy bodies and Lewy neurites. The etiology of PD remains unclear. Because brain injury has been suggested to facilitate αsyn aggregation, we investigated whether cellular breakdown products from damaged cells can act on neighboring healthy cells and cause intracellular αsyn accumulation and/or aggregation. Using 2 neuronal cell models, we found that extracellular adenosine triphosphate (ATP) induced a significant increase in intracellular αsyn levels between 24 and 48 hours after treatment. Further investigation revealed that the observed αsyn accumulation is a result of lysosome dysfunction caused by extracellular ATP-induced elevation of lysosomal pH. Interestingly, P2X1 receptor appears to mediate the cells' response to extracellular ATP. Although Ca2+ influx via P2X1 receptor is necessary for αsyn accumulation, Ca2+ influx per se is not sufficient for increased αsyn accumulation. These findings provide new insight into our knowledge of the role of P2X receptors in PD pathogenesis and may be helpful in identifying new therapeutic targets for PD.

Introduction

Parkinson's disease (PD) is the second most common neurodegenerative disorder, pathologically characterized by the formation of filamentous alpha-synuclein (αsyn) neuronal inclusions and the loss of dopaminergic neurons in substantia nigra and dopaminergic terminals in the striatum (Dauer and Przedborski, 2003). The etiology of PD remains unclear and no disease-modifying treatment currently exists. Misfolding and aggregation of αsyn plays a central role in the pathogenesis of PD (Jellinger, 2012). Among the variety of aggregate species present, low-molecular weight oligomers, ranging from 2 to 30 mers are thought to be the primary neurotoxic species responsible for the impairment of neuronal function in PD (Planchard et al., 2014). Traumatic brain injury (TBI) has been considered a causative factor for PD based on case-control studies (Lee et al., 2012), and brain injury has been suggested to facilitate αsyn aggregation and PD development (Bramlett and Dietrich, 2003, Jafari et al., 2013). This notion is further supported in an experimental study showing that αsyn expression and aggregation increased transiently following TBI in aged mouse brain (Uryu et al., 2003). Focal cerebral ischemia was also found to induce both the aggregation of wild type and transgenic human mutant (A30P) αsyn in mouse brain (Unal-Cevik et al., 2011), and a recent study further linked ischemia to PD by showing early development of brain injury caused neuronal loss in substantia nigra in a mouse focal cerebral ischemia model (Rodriguez-Grande et al., 2013). Despite these intriguing data, the exact mechanism(s) underlying brain injury-induced aggregation of αsyn remain elusive. Considering that the aforementioned αsyn aggregation only appears approximate to the injured area and αsyn aggregates form in a relatively short time (from 3 days to 1 week) after brain injury (Uryu et al., 2003), we hypothesized that cellular breakdown products from damaged cells may influence neighboring healthy neuronal cells leading to intracellular αsyn accumulation and/or aggregation. Herein, we tested whether extracellular adenosine triphosphate (ATP) might be a key factor, inducing αsyn accumulation in the previously scenario because ATP acts as a potent stimulus for inflammation and can be released from damaged cells. Extracellular ATP plays an important signaling role by activating broadly distributed cell surface purinergic receptors (P2 receptors) (Seminario-Vidal et al., 2009). P2 receptors are divided into 2 subclasses, ATP-selective cation channels P2X and G-protein-coupled P2Y families. Functional P2X receptors are expressed on both neurons and glial cells (Volonte et al., 2003). So far, 7 members of P2X subfamily have been identified, P2X1-7 (Falzoni et al., 2013). In the present study, we confirm that extracellular ATP plays an important role in intracellular αsyn aggregation in 2 different neuronal cell models and further demonstrate that lysosomal dysfunction is linked to extracellular ATP-induced αsyn accumulation in neuronal cells. Importantly, we found that P2X1 receptors are key to mediating the observed effects.

Section snippets

Chemicals

The following chemicals were used in the present study. ATP (Sigma, A7699), ADP (Sigma, A2754), AMP (Sigma, A1752), and bafilomycin A1 (Sigma, 196000), Cycloheximide (Sigma, C7698), A23187 (Sigma, C7522), ATPγS (R&D system, 4080), BzATP (R&D system, 3312), NF449 (R&D system, 1391), TNP-ATP (R&D system, 2464), and A438079 (R&D system, 2972), PSB-12062 (Glixx Laboratories, 01,919).

Generation of tetracycline-off inducible αsyn-overexpressing H4 cells

A bidirectional and tetracycline-driven expression plasmid was constructed by combining pTRE3G-BI (Clontech, CA, USA)

Dying cells induce αsyn oligomerization in surrounding healthy cells

TBI is a poorly understood risk factor for Parkinson's disease (Jellinger, 2012, Stern, 1991) and studies in animal models have shown that TBI induces the rapid accumulation of many key proteins that form pathologic aggregates in neurodegenerative diseases including αsyn (Uryu et al., 2007). Cells damaged by traumatic brain injury or focal cerebral ischemia can die by both apoptosis and necrosis (Bramlett and Dietrich, 2004, Clark et al., 1997). To determine if either of these pathways can

Discussion

ATP is a potent signaling molecule abundantly present in the central nervous system (Apolloni et al., 2009, Prasai et al., 2011). Extracellular ATP induces various biological responses which are mediated by the activation of cell surface receptors including ligand-gated ion channels (P2X) and G-protein coupled (P2Y) receptor subtypes. High concentrations (approximately 10 mM) of ATP are present in the cellular cytoplasm, whereas low concentrations (1–10 nM) can be found in the extracellular

Disclosure statement

The authors declare that they have no conflicts of interest.

Acknowledgements

This work was supported by NIH NS 073740 (Pamela J. McLean) and the Mayo Clinic. The authors thank Ann-Marie Baine for excellent technical assistance.

References (53)

  • K. Uryu et al.

    Age-dependent synuclein pathology following traumatic brain injury in mice

    Exp. Neurol.

    (2003)
  • T. Vogiatzi et al.

    Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells

    J. Biol. Chem.

    (2008)
  • S. Apolloni et al.

    Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events

    FEBS J.

    (2009)
  • M.J. Bours et al.

    P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation

    Front Biosci. (Schol. Ed.)

    (2011)
  • H.M. Bramlett et al.

    Pathophysiology of cerebral ischemia and brain trauma: similarities and differences

    J. Cereb. Blood Flow Metab.

    (2004)
  • R.S. Clark et al.

    Apoptosis-suppressor gene bcl-2 expression after traumatic brain injury in rats

    J. Neurosci.

    (1997)
  • K.M. Danzer et al.

    Exosomal cell-to-cell transmission of alpha synuclein oligomers

    Mol. Neurodegener.

    (2012)
  • K.M. Danzer et al.

    Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity

    FASEB J.

    (2011)
  • F. Di Virgilio et al.

    Extracellular ATP, P2 receptors, and inflammation

    Drug Dev. Res.

    (2003)
  • M. Diaz-Hernandez et al.

    Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration

    FASEB J.

    (2009)
  • D. Ebrahimi-Fakhari et al.

    Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein

    J. Neurosci.

    (2011)
  • S. Falzoni et al.

    Detecting adenosine triphosphate in the pericellular space

    Interface Focus

    (2013)
  • A.V. Gourine et al.

    Release of ATP in the central nervous system during systemic inflammation: real-time measurement in the hypothalamus of conscious rabbits

    J. Physiol.

    (2007)
  • S. Guha et al.

    Lysosomal alkalinization, lipid oxidation, and reduced phagosome clearance triggered by activation of the P2X7 receptor

    FASEB J.

    (2013)
  • R.R. Hodges et al.

    Identification of P2X(3) and P2X(7) purinergic receptors activated by ATP in rat lacrimal gland

    Invest. Ophthalmol. Vis. Sci.

    (2011)
  • Z. Hracsko et al.

    Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease

    Mol. Neurodegener.

    (2011)
  • Cited by (0)

    View full text